OR WAIT null SECS
May 09, 2023
The new agreement is based off the Master Services Agreement that both companies entered in 2021 for the development, manufacture, and supply of rhenium (186Re) obisbemeda, according to a press release.
May 08, 2023
These models are useful in predicting whether an unknown substance of abuse can permeate the BBB to produce effects predicted by the Public Health Assessment via Structural Evaluation (PHASE) approach.
The recent revision is intended to provide guidance on QRM principles and tools that can be used for different aspects of pharmaceutical quality.
May 04, 2023
Presspart will still be responsible for the manufacturing of the Sunriser device.
May 03, 2023
mRNA therapeutics are being researched to support the fight against rare diseases, infectious viruses, and cancers.
Competition in the organ-on-a-chip market increases as NETRI enters the arena.
May 02, 2023
This specific guidance refers to a DCT as a clinical trial where some or all the trial-related activities occur at locations other than traditional clinical trial sites.
The new research and development capacities set the stage for completion of product development for LEON’s manufacturing devices and will be used to showcase the devices and provide process development services to clients using LEON’s equipment.
The acquisition was completed through the merger of a wholly owned subsidiary of Sanofi with and into Provention Bio.
Strike action is impacting numerous sectors across Europe, including the bio/pharma industry.